These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21569500)

  • 1. Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1.
    Hayes AM; Qian S; Yu L; Boris-Lawrie K
    Retrovirology; 2011 May; 8():36. PubMed ID: 21569500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
    Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
    DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.
    Rossenkhan R; Novitsky V; Sebunya TK; Musonda R; Gashe BA; Essex M
    PLoS One; 2012; 7(5):e35491. PubMed ID: 22590503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of HIV-1 in vitro by combination of vpr and tat specific short hairpin RNA via lentiviral vectors].
    Hao YZ; Teng ZP; Yang YS; Sun XN; Ma J; Jin XH; Zeng Y
    Bing Du Xue Bao; 2013 Mar; 29(2):126-31. PubMed ID: 23757841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation.
    Okumura A; Alce T; Lubyova B; Ezelle H; Strebel K; Pitha PM
    Virology; 2008 Mar; 373(1):85-97. PubMed ID: 18082865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1.
    Qian S; Zhong X; Yu L; Ding B; de Haan P; Boris-Lawrie K
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):605-10. PubMed ID: 19122141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: functional and pathogenic implications of genetic variation.
    Neogi U; Sood V; Banerjee S; Ghosh N; Verma S; Samrat S; Sharma Y; Saxena A; Husain S; Ramachandran VG; Das S; Sreedhar KV; Goel N; Wanchu A; Banerjea AC
    Indian J Exp Biol; 2009 Jun; 47(6):424-31. PubMed ID: 19634706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
    Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
    Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription.
    Faust TB; Binning JM; Gross JD; Frankel AD
    Annu Rev Virol; 2017 Sep; 4(1):241-260. PubMed ID: 28961413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.
    Wang J; Shackelford JM; Casella CR; Shivers DK; Rapaport EL; Liu B; Yu XF; Finkel TH
    Virology; 2007 Mar; 359(2):243-52. PubMed ID: 17056089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-Vitro Subtype-Specific Modulation of HIV-1 Trans-Activator of Transcription (Tat) on RNAi Silencing Suppressor Activity and Cell Death.
    Ronsard L; Yousif AS; Ramesh J; Sumi N; Gorman M; Ramachandran VG; Banerjea AC
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31652847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 accessory proteins--ensuring viral survival in a hostile environment.
    Malim MH; Emerman M
    Cell Host Microbe; 2008 Jun; 3(6):388-98. PubMed ID: 18541215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 Vpr: functions and molecular interactions.
    Romani B; Engelbrecht S
    J Gen Virol; 2009 Aug; 90(Pt 8):1795-1805. PubMed ID: 19458171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4
    Bauby H; Ward CC; Hugh-White R; Swanson CM; Schulz R; Goujon C; Malim MH
    mBio; 2021 Jun; 12(3):e0136921. PubMed ID: 34154423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of viral regulatory and accessory proteins in HIV-1 replication.
    Seelamgari A; Maddukuri A; Berro R; de la Fuente C; Kehn K; Deng L; Dadgar S; Bottazzi ME; Ghedin E; Pumfery A; Kashanchi F
    Front Biosci; 2004 Sep; 9():2388-413. PubMed ID: 15353294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine.
    Sultana S; Li H; Puche A; Jones O; Bryant JL; Royal W
    J Neurovirol; 2010 Feb; 16(1):33-40. PubMed ID: 20113193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZBTB2 represses HIV-1 transcription and is regulated by HIV-1 Vpr and cellular DNA damage responses.
    Bruce JW; Bracken M; Evans E; Sherer N; Ahlquist P
    PLoS Pathog; 2021 Feb; 17(2):e1009364. PubMed ID: 33635925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
    Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
    Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
    Schwartz S; Felber BK; Pavlakis GN
    Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.